Agilent Technologies and Sage Science have signed an agreement to co-market their nucleic acid sample-prep systems, the companies said today.
Under the pact, the companies will co-promote Agilent's 2100 Bioanalyzer, which is used for detecting and quantifying nucleic acids, with Sage's Pippin Prep DNA size-selection system.
Agilent and Sage also said that they will conduct studies to explore use of the systems together in next-generation sequencing applications.
In a statement, Sage CEO Gary Magnant said that the products are "clearly complementary for the size-selection steps in next-generation sequencing." Magnant also noted that Agilent's 2100 Bioanalyzer kits provide "superb analysis of DNA size distributions, with minimal sample consumption."
Sage's Pippin Prep is a preparative gel electrophoresis system that also automates the separation and recovery of different sized DNA fragments. The company said that sequencing libraries generated with Pippin Prep have greater sequence diversity and less low molecular weight contamination than those produced by traditional gel methods, generating a greater amount of higher quality sequencing data per run.
In October, Sage Science inked an agreement with Illumina, under which Illumina is promoting Pippin Prep for use in next-generation sequencing applications (PCR Insider, 10/21/10).